Rae Taub

Title: Rae Taub: Innovator in Antiparasitic Compounds

Introduction

Rae Taub is a notable inventor based in Metuchen, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of novel ivermectin derivatives. With a total of 2 patents, her work has the potential to impact the treatment of parasitic infections.

Latest Patents

Rae Taub's latest patents include innovative compounds and processes related to ivermectin. The first patent discloses novel ivermectin compounds that contain straight chain or branched fatty acid residues ranging from about C2 to about C20. These compounds are prepared through a specific process that enhances their efficacy. The second patent focuses on new derivatives of C-076 compounds, which have been isolated from the livers of animals administered ivermectin. These derivatives retain the basic ivermectin structure while exhibiting modifications that enhance their biological activity as potent antiparasitic agents.

Career Highlights

Rae Taub is currently associated with Merck & Co., Inc., a leading global healthcare company. Her work at Merck has allowed her to contribute to groundbreaking research in the field of antiparasitic treatments.

Collaborations

Throughout her career, Rae has collaborated with esteemed colleagues such as Rudolf P Buhs and Theodore A Jacob. These collaborations have further enriched her research and development efforts.

Conclusion

Rae Taub's innovative work in the field of ivermectin derivatives showcases her dedication to advancing medical science. Her contributions have the potential to lead to more effective treatments for parasitic infections, highlighting her importance as an inventor in the pharmaceutical industry.